7
report
Models for Financing Antibiotic Development to Address Antimicrobial Resistance
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to id
report
Demographic Reporting and Mix in Clinical Trials
Clinical trial enrollment can vary based on demographics. Cancer drug trials, for example, have bee
n shown to skew disproportionately toward young, White, male participants.
+ Read More
article
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
Submitted electronically
Dr. Robert Califf
Commissioner
US Food and Drug Administration
Silver Spri
ng, MD 20993
Dear Dr. Califf,
+ Read More
article
Medicare Drug Price Negotiation Program comment letter
Submitted electronically
Dr. Meena Seshamani
Deputy Administrator and Director, Center for Medicare
Centers for Medicare & Medicaid Services
US Department of Health and Human Services
Baltimore, MD 21244
+ Read More
video
December 6 at 3:30 pm EST | Time=Lives and Overcoming Challenges to Drug Repurposing
New drugs can take more than a decade to develop and get to market.
video
December 6 at 7:15 pm EST | Future of Health Summit Dinner | A Commitment to Accelerating Cures: The Future of Biomedical Innovation
The new year will begin with fresh leadership at several of the nation's top scientific agencies.
Hear from Dr. Bertagnolli and Dr.
+ Read More
video
December 7 at 8:30 am EST | Part 1: A Conversation with FDA Commissioner Robert Califf
Welcoming Remarks
Esther Krofah
Executive Vice President, MI Health, Milken Institute